Lusaris Therapeutics
Morrisville, US · Founded 2021 · Delaware corporation · 5 known investors
Find your way into Lusaris Therapeutics
Sign up to see every warm intro you have to Lusaris Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lusaris Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RF
Ramin Farzaneh-FarNamed on SEC filing
AL
Andrew LevinNamed on SEC filing
CR
Catherine RiesenNamed on SEC filing
DG
Daniel GrauNamed on SEC filing
EM
Edward MonaghanNamed on SEC filing
NB
Neil BuckleyNamed on SEC filing
Investors · 5
RA CapitalreportedBoston
How we know: funding news · biospace.com · Not right? Tell us
Venrock Healthcare Capital PartnersreportedNew York
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 2
Boxer CapitalDeep Track Capital
Funding
SEC filings, press & company announcements$60.2M disclosed across 1 of 2 rounds · 2022–2023
- Undisclosed amountSeries ASep 2023
Boxer Capital, Deep Track Capital, RA capital management, Venrock Healthcare Capital Partners
Source ↗
▶$60.2MraisedDec 2022 · 9 investors · PharmaceuticalsRule 506(b)
▶$60.2MraisedDec 2022 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramin Farzaneh-FarExecutive Officer
- Andrew LevinExecutive Officer, Director
- Catherine RiesenExecutive Officer
- Daniel GrauDirector
- Edward MonaghanExecutive Officer, Director, Promoter
- Neil BuckleyExecutive Officer
- Offering amount
- $60.2M
- Amount sold
- $60.2M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Lusaris Therapeutics's investors?
- Lusaris Therapeutics's investors include RA Capital, Venrock, Venrock Healthcare Capital Partners.
- How much funding has Lusaris Therapeutics raised?
- Lusaris Therapeutics has disclosed $60.2M raised across 1 of its 2 known rounds.
- Where is Lusaris Therapeutics headquartered?
- Lusaris Therapeutics is headquartered in Morrisville, US.

